Cited by 89Cancer-related cognitive impairment studiesCancer survivorship and careMenopause: Health Impacts and Treatments

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls

Palmer, Jaime L., Trotter, Theresa, Joy, Anil A., Carlson, Linda E.·2008·Journal of Cancer Survivorship

Abstract

Introduction The selective estrogen receptor modulator, Tamoxifen (TAM), is one of the most frequently prescribed drugs for the treatment of breast cancer; however, its effects on the cognition of users have not been adequately studied. Although TAM is an effective anti-estrogen that blocks tumour growth in the breast, it could also influence the activity of other target estrogen sites, including the brain. The exact nature of this interaction is unknown.Methods A cross-sectional design was used to compare cognitive task performance of two treatment groups: 1) women using TAM for the treatment of early breast cancer (n = 23); and 2) age-matched, healthy women not using TAM (n = 23). All participants were pre-menopausal, and recipients of chemotherapy were excluded from the study.Results It was found that TAM users scored significantly worse than controls on tasks of immediate and delayed visual memory, verbal fluency, immediate verbal memory, visuo-spatial ability, and processing speed.Discussions/conclusions Although limited by the lack of baseline data and pre-morbid intelligence measures, the results of this exploratory study suggest that at least in pre-menopausal women, TAM may exert a widespread negative influence on cognitive abilities.Implications for cancer survivors Larger, randomized, prospective trials are required to confirm these results; however, TAM use in pre-menopausal breast cancer may be associated with cognitive difficulties. Knowledge and understanding of these complications will be important for professionals in communicating both the benefits and risks of TAM use in breast cancer survivors.

Integrity signals

Registry

Crossref · 10.1007/s11764-008-0070-1

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 46 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Palmer, J. L., Trotter, T., Joy, A. A., & Carlson, L. E.
Affiliations
  • University of Calgary (CA)
  • Cross Cancer Institute (CA)
Corresponding author
Carlson, Linda E.
Venue
Journal of Cancer Survivorship
Published
2008-10-16
Volume
2
Issue
4
Pages
275-282
ISSN
  • 1932-2259 (ISSN-L)
  • 1932-2267
OpenAlex
W1982544366
Cited by
89
References
46
Citations by year
2026: 4 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 10 · 2016: 5 · 2015: 6 · 2014: 7 · 2013: 8 · 2012: 2
FWCI
6.45
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cancer Survivorship (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
tamoxifen, breast cancer, cognitive effects, premenopausal women, selective estrogen receptor modulators, visual memory, verbal fluency, visuospatial ability, processing speed, cognitive impairment, cancer survivors, adverse drug reactions
MeSH terms
Adult, Breast Neoplasms, Cognition, Cross-Sectional Studies, Female, Health, Humans, Middle Aged, Neuropsychological Tests, Retrospective Studies, Tamoxifen, Case-Control Studies, Premenopause, Antineoplastic Agents, Hormonal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review